Clinical trial · Observational
Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma
NCT05134961CI-TRIAL-00055260completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to examine the long-term outcomes after curatively intended resection of duodenal adenocarcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Duodenal Cancer | Malignant Duodenal Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pancreaduodenectomy and possible adjuvant therapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients undergoing resection of primary duodenal cancer
- description
- Tumors comprised histologically confirmed adenocarcinomas in the duodenum excluding adenocarcinoma of the ampulla of Vater and adenocarcinomas with gastric and pancreato-biliary morphology and immunohistochemistry.
- interventionNames
- Procedure: Pancreaduodenectomy and possible adjuvant therapy
Primary outcomes (1)
- measure
- 3-year survival
- timeFrame
- Three years
- description
- Cumulative survival after three years
Secondary outcomes (1)
- measure
- Duodenal cancer recurrence
- timeFrame
- 5 years
- description
- Recurrence found by computed tomography scan
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients subjected to resection of primary duodenal adenocarcinoma Exclusion Criteria: * None.
References
Publications (0)
Data not yet available
No reference posted for this study.